Skip to main content
. 2020 Sep 18;8(2):73–78. doi: 10.5152/eurjrheum.2020.20102

Figure 1.

Figure 1

Number of flares per months before (blue) and after (red) colchicine treatment. A significant decrease in the median number of flares (8; IQR=7–14 vs 3; IQR=2–4; p=0.005) was observed [MEFV (+): cases with heterozygous MEFV gene mutations; MEFV (−): cases without heterozygous, IQR: interquartile range].